Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice
K Shang, YP Bai, C Wang, Z Wang, HY Gu, X Du… - PloS one, 2012 - journals.plos.org
Ulcerative colitis (UC) is a major form of chronic inflammation that can frequently progress to
colon cancer. Several studies have demonstrated massive infiltration of neutrophils and …
colon cancer. Several studies have demonstrated massive infiltration of neutrophils and …
Isotretinoin use and the risk of inflammatory bowel disease: a case–control study
SD Crockett, CQ Porter, CF Martin… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: Isotretinoin is commonly prescribed for the treatment of severe acne.
Although cases of inflammatory bowel disease (IBD) have been reported in isotretinoin …
Although cases of inflammatory bowel disease (IBD) have been reported in isotretinoin …
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases
H Ali, B Weigmann, MF Neurath, EM Collnot… - Journal of Controlled …, 2014 - Elsevier
The purpose of this study was to investigate the therapeutic potential of budesonide loaded
nanocarriers for the treatment of inflammatory bowel disease (IBD). First, budesonide was …
nanocarriers for the treatment of inflammatory bowel disease (IBD). First, budesonide was …
Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in …
L Frolova, P Drastich, P Rossmann… - … of Histochemistry & …, 2008 - journals.sagepub.com
Dysregulation of innate and adaptive intestinal immune responses to bacterial microbiota is
supposed to be involved in pathogenetic mechanisms of inflammatory bowel diseases …
supposed to be involved in pathogenetic mechanisms of inflammatory bowel diseases …
Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey
Aim To investigate the epidemiologic and clinical characteristics of inflammatory bowel
disease (IBD) patients in a large multicenter, countrywide, hospital-based study in Turkey …
disease (IBD) patients in a large multicenter, countrywide, hospital-based study in Turkey …
The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease–a phase 1 trial with three doses
T Dhere, I Copland, M Garcia… - Alimentary …, 2016 - Wiley Online Library
Background Mesenchymal stromal cells ability to reset immune functionalities may be useful
in Crohn's disease. Aim To perform a first‐in‐human phase 1 safety clinical trial of …
in Crohn's disease. Aim To perform a first‐in‐human phase 1 safety clinical trial of …
Retinoic acid, leaky gut, and autoimmune diseases
L Abdelhamid, XM Luo - Nutrients, 2018 - mdpi.com
A leaky gut has been observed in a number of autoimmune diseases including type 1
diabetes, multiple sclerosis, inflammatory bowel disease, and systemic lupus …
diabetes, multiple sclerosis, inflammatory bowel disease, and systemic lupus …
Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties
XL Chen, L Zhong, Y Wen, TW Liu, XY Li… - Health and quality of life …, 2017 - Springer
Background This review aims to critically appraise and compare the measurement
properties of inflammatory bowel disease (IBD)-specific health-related quality of life …
properties of inflammatory bowel disease (IBD)-specific health-related quality of life …
Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis
Background Resolvin E1 (RvE1), an endogenous lipid mediator derived from
eicosapentaenoic acid, has been identified in local inflammation during the healing stage …
eicosapentaenoic acid, has been identified in local inflammation during the healing stage …
Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial
K Yoshida, K Fukunaga, H Ikeuchi… - Inflammatory bowel …, 2012 - academic.oup.com
Background Infliximab (IFX) is effective for remission induction and maintenance of Crohn's
disease (CD). This trial assessed the efficacy of scheduled maintenance IFX monotherapy to …
disease (CD). This trial assessed the efficacy of scheduled maintenance IFX monotherapy to …